Published in

Taylor and Francis Group, Expert Review of Clinical Immunology, 10(19), p. 1281-1291, 2023

DOI: 10.1080/1744666x.2023.2240514

Links

Tools

Export citation

Search in Google Scholar

Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies – real-world data from the IG TATRY study

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO